Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary M Pollack

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|May 2, 2003
Modulation of P-glycoprotein transport activity in the mouse blood-brain barrier by rifampinJian Zong, Gary M Pollack
Biochemical Pharmacology|June 16, 2009
Regional differences in capillary density, perfusion rate, and P-glycoprotein activity: a quantitative analysis of regional drug exposure in the brainRong Zhao, Gary M Pollack
Journal of Pharmacokinetics and Pharmacodynamics|October 11, 2011
The influence of distributional kinetics into a peripheral compartment on the pharmacokinetics of substrate partitioning between blood and brain tissueJeannie M Padowski, Gary M Pollack
Pharmaceutical Research|September 2, 2003
P-Glycoprotein attenuates brain uptake of substrates after nasal instillationCandace L Graff, Gary M Pollack
Pharmaceutical Research|December 28, 2006
Kinetic considerations for the quantitative assessment of efflux activity and inhibition: implications for understanding and predicting the effects of efflux inhibitionJ Cory Kalvass, Gary M Pollack
American Journal of Pharmaceutical Education|November 13, 2008
Using answer-until-correct examinations to provide immediate feedback to students in a pharmacokinetics courseAdam M Persky, Gary M Pollack
Pharmacotherapy|January 28, 2009
Training clinical pharmaceutical scientists in today's highly competitive times: it's time to commit to changeRobert A Blouin, Gary M Pollack
Brain Research|September 18, 2004
Pharmacodynamics of morphine-induced neuronal nitric oxide production and antinociceptive tolerance developmentErin L Heinzen, Gary M Pollack
Journal of Pharmaceutical Sciences|February 4, 2010
Examination of the ability of the nasal administration route to confer a brain exposure advantage for three chemical inhibitors of P-glycoproteinJeannie M Padowski, Gary M Pollack
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 21, 2012
Influence of enterohepatic recycling on the time course of brain-to-blood partitioning of valproic acid in ratsJeannie M Padowski, Gary M Pollack
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
The Journal of Pharmacology and Experimental Therapeutics|May 2, 2003
Modulation of P-glycoprotein transport activity in the mouse blood-brain barrier by rifampinJian Zong, Gary M Pollack
Biochemical Pharmacology|June 16, 2009
Regional differences in capillary density, perfusion rate, and P-glycoprotein activity: a quantitative analysis of regional drug exposure in the brainRong Zhao, Gary M Pollack
Journal of Pharmacokinetics and Pharmacodynamics|October 11, 2011
The influence of distributional kinetics into a peripheral compartment on the pharmacokinetics of substrate partitioning between blood and brain tissueJeannie M Padowski, Gary M Pollack
Pharmaceutical Research|September 2, 2003
P-Glycoprotein attenuates brain uptake of substrates after nasal instillationCandace L Graff, Gary M Pollack
Pharmaceutical Research|December 28, 2006
Kinetic considerations for the quantitative assessment of efflux activity and inhibition: implications for understanding and predicting the effects of efflux inhibitionJ Cory Kalvass, Gary M Pollack
American Journal of Pharmaceutical Education|November 13, 2008
Using answer-until-correct examinations to provide immediate feedback to students in a pharmacokinetics courseAdam M Persky, Gary M Pollack
Pharmacotherapy|January 28, 2009
Training clinical pharmaceutical scientists in today's highly competitive times: it's time to commit to changeRobert A Blouin, Gary M Pollack
Brain Research|September 18, 2004
Pharmacodynamics of morphine-induced neuronal nitric oxide production and antinociceptive tolerance developmentErin L Heinzen, Gary M Pollack
Journal of Pharmaceutical Sciences|February 4, 2010
Examination of the ability of the nasal administration route to confer a brain exposure advantage for three chemical inhibitors of P-glycoproteinJeannie M Padowski, Gary M Pollack
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 21, 2012
Influence of enterohepatic recycling on the time course of brain-to-blood partitioning of valproic acid in ratsJeannie M Padowski, Gary M Pollack
Pageof 6